Search research articles
Contact Us
Filters
Showing results (181-190 of 443) with videos related to
Page
of 45
Sort By:
Haematologica
|
August 27, 2016
Sequential regimen of clofarabine, cytosine arabinoside and reduced-intensity conditioned transplantation for primary refractory acute myeloid leukemia
Mohamad Mohty, Florent Malard, Didier Blaise, et al.
American Journal of Hematology
|
July 24, 2018
Thiotepa, busulfan and fludarabine compared to busulfan and cyclophosphamide as conditioning regimen for allogeneic stem cell transplant from matched siblings and unrelated donors for acute myeloid leukemia
Francesco Saraceni, Eric Beohou, Myriam Labopin, et al.
Bone Marrow Transplantation
|
February 2, 2022
Non-T depleted haploidentical stem cell transplantation in AML patients achieving first complete remission after one versus two induction courses: a study from the ALWP/EBMT
Arnon Nagler, Myriam Labopin, Xiao-Jun Huang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 11, 2019
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Age >69 Years with Acute Myelogenous Leukemia: On Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Olle Ringdén, Ariane Boumendil, Myriam Labopin, et al.
Bone Marrow Transplantation
|
May 16, 2019
Prospective phase II study of prophylactic low-dose azacitidine and donor lymphocyte infusions following allogeneic hematopoietic stem cell transplantation for high-risk acute myeloid leukemia and myelodysplastic syndrome
Thierry Guillaume, Florent Malard, Leonardo Magro, et al.
American Journal of Hematology
|
November 21, 2018
Hematopoietic stem cell transplantation for adult patients with isolated NPM1 mutated acute myeloid leukemia in first remission
Xavier Poiré, Myriam Labopin, Emmanuelle Polge, et al.
Bone Marrow Transplantation
|
October 25, 2019
Fludarabine/busulfan versus fludarabine/total-body-irradiation (2 Gy) as conditioning prior to allogeneic stem cell transplantation in patients (≥60 years) with acute myelogenous leukemia: a study of the acute leukemia working party of the EBMT
Thomas Heinicke, Myriam Labopin, Emmanuelle Polge, et al.
American Journal of Hematology
|
July 14, 2020
Impact of total body irradiation- vs chemotherapy-based myeloablative conditioning on outcomes of haploidentical hematopoietic cell transplantation for acute myelogenous leukemia
Bhagirathbhai Dholaria, Myriam Labopin, Emanuele Angelucci, et al.
Bone Marrow Transplantation
|
June 1, 2021
Allogeneic stem cell transplantation for AML patients with RUNX1 mutation in first complete remission: a study on behalf of the acute leukemia working party of the EBMT
Johanna Waidhauser, Myriam Labopin, Jordi Esteve, et al.
Frontiers in Immunology
|
July 24, 2019
Allogeneic HSCT for Autoimmune Diseases: A Retrospective Study From the EBMT ADWP, IEWP, and PDWP Working Parties
Raffaella Greco, Myriam Labopin, Manuela Badoglio, et al.
Page
of 45
Search research articles
Search
Showing results (181-190 of 443) with videos related to
Sort By:
Page
of 45
Haematologica
|
August 27, 2016
Sequential regimen of clofarabine, cytosine arabinoside and reduced-intensity conditioned transplantation for primary refractory acute myeloid leukemia
Mohamad Mohty, Florent Malard, Didier Blaise, et al.
American Journal of Hematology
|
July 24, 2018
Thiotepa, busulfan and fludarabine compared to busulfan and cyclophosphamide as conditioning regimen for allogeneic stem cell transplant from matched siblings and unrelated donors for acute myeloid leukemia
Francesco Saraceni, Eric Beohou, Myriam Labopin, et al.
Bone Marrow Transplantation
|
February 2, 2022
Non-T depleted haploidentical stem cell transplantation in AML patients achieving first complete remission after one versus two induction courses: a study from the ALWP/EBMT
Arnon Nagler, Myriam Labopin, Xiao-Jun Huang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 11, 2019
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Age >69 Years with Acute Myelogenous Leukemia: On Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Olle Ringdén, Ariane Boumendil, Myriam Labopin, et al.
Bone Marrow Transplantation
|
May 16, 2019
Prospective phase II study of prophylactic low-dose azacitidine and donor lymphocyte infusions following allogeneic hematopoietic stem cell transplantation for high-risk acute myeloid leukemia and myelodysplastic syndrome
Thierry Guillaume, Florent Malard, Leonardo Magro, et al.
American Journal of Hematology
|
November 21, 2018
Hematopoietic stem cell transplantation for adult patients with isolated NPM1 mutated acute myeloid leukemia in first remission
Xavier Poiré, Myriam Labopin, Emmanuelle Polge, et al.
Bone Marrow Transplantation
|
October 25, 2019
Fludarabine/busulfan versus fludarabine/total-body-irradiation (2 Gy) as conditioning prior to allogeneic stem cell transplantation in patients (≥60 years) with acute myelogenous leukemia: a study of the acute leukemia working party of the EBMT
Thomas Heinicke, Myriam Labopin, Emmanuelle Polge, et al.
American Journal of Hematology
|
July 14, 2020
Impact of total body irradiation- vs chemotherapy-based myeloablative conditioning on outcomes of haploidentical hematopoietic cell transplantation for acute myelogenous leukemia
Bhagirathbhai Dholaria, Myriam Labopin, Emanuele Angelucci, et al.
Bone Marrow Transplantation
|
June 1, 2021
Allogeneic stem cell transplantation for AML patients with RUNX1 mutation in first complete remission: a study on behalf of the acute leukemia working party of the EBMT
Johanna Waidhauser, Myriam Labopin, Jordi Esteve, et al.
Frontiers in Immunology
|
July 24, 2019
Allogeneic HSCT for Autoimmune Diseases: A Retrospective Study From the EBMT ADWP, IEWP, and PDWP Working Parties
Raffaella Greco, Myriam Labopin, Manuela Badoglio, et al.
Page
of 45